Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck

被引:0
|
作者
Anna-Maria A. De Costa
Corinne A. Schuyler
David D. Walker
M. Rita I. Young
机构
[1] Ralph H. Johnson Veterans Affairs Medical Center,Research Service (151)
[2] Medical University of South Carolina,Department of Otolaryngology, Head and Neck Surgery
[3] Medical University of South Carolina,Department of Medicine
来源
Cancer Immunology, Immunotherapy | 2012年 / 61卷
关键词
HNSCC; Premalignant; Immunoediting; Th1/Tc1 cells; Th17 cells;
D O I
暂无
中图分类号
学科分类号
摘要
While studies have indicated that squamous cell carcinoma of the head and neck (HNSCC) is associated with immune suppression, these studies did not analyze the immune response at the dysplastic stage. The present study utilized a mouse model of 4-nitroquinoline 1-oxide-induced oral carcinogenesis to examine the alterations in immune phenotype at the premalignant and malignant stages of HNSCC. Cervical lymph nodes of HNSCC-bearing mice were found to contain a greater number of cells, including a greater number of conventional (Tconv) and regulatory (Treg) T cells, compared to cervical lymph nodes of control and premalignant lesion-bearing mice, though the Tconv cells appear to be less proliferative and the Treg cells appear to be less suppressive at the HNSCC stage. Premalignant lesion-bearing mouse lymph nodes consist of a greater percentage of Tconv cells expressing markers for activation, memory, and exhaustion compared to both control and HNSCC-bearing mice. Also, lymph nodes’ cells from both premalignant lesion-bearing and HNSCC-bearing mice include increased levels of Th1, Tc1, and Th17 cells, with no differences in levels of Th2 cells, compared to control mice. The data show that while there is the expected increase in immunosuppressive Tregs in lymph nodes when HNSCC is present, there is also an unexpected increase in immune populations usually associated with a beneficial antitumor response, including Tconv cells and Th1 and Tc1 cells. In addition, the results demonstrate that the premalignant stage of HNSCC development is associated with a robust immune response involving an increase in inflammatory Th1, Tc1, and Th17 cells.
引用
收藏
页码:927 / 939
页数:12
相关论文
共 50 条
  • [1] Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck
    De Costa, Anna-Maria A.
    Schuyler, Corinne A.
    Walker, David D.
    Young, M. Rita I.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (06) : 927 - 939
  • [2] Molecular progression of head and neck squamous cell carcinoma
    Saha S.K.
    Maiti G.P.
    Roychoudhury S.
    Panda C.K.
    The Nucleus, 2017, 60 (2) : 111 - 119
  • [3] Pyroptosis patterns and immune infiltrates characterization in head and neck squamous cell carcinoma
    Deng, Hongxia
    Wei, Zhengyu
    Qiu, Shijie
    Ye, Dong
    Gu, Shanshan
    Shen, Yi
    Shen, Zhisen
    Jin, Yangli
    Zhou, Chongchang
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (04)
  • [4] Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma
    Callejas-Valera, Juan L.
    Vermeer, Daniel W.
    Lucido, Christopher T.
    Williamson, Caitlin
    Killian, Marisela
    Vermeer, Paola D.
    Spanos, William C.
    Powell, Steven F.
    CANCERS, 2022, 14 (10)
  • [5] The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC)
    F Hakami
    L Darda
    P Stafford
    P Woll
    D W Lambert
    K D Hunter
    British Journal of Cancer, 2014, 111 : 807 - 816
  • [6] The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC)
    Hakami, F.
    Darda, L.
    Stafford, P.
    Woll, P.
    Lambert, D. W.
    Hunter, K. D.
    BRITISH JOURNAL OF CANCER, 2014, 111 (04) : 807 - 816
  • [7] Characterization of the immune cell function landscape in head and neck squamous carcinoma to assist in prognosis prediction and immunotherapy
    Wang, Wenlun
    Zhang, Zhouyi
    Li, Wenming
    Wei, Dongmin
    Xu, Jianing
    Qian, Ye
    Cao, Shengda
    Lei, Dapeng
    AGING-US, 2023, 15 (21): : 12588 - 12617
  • [8] Head and neck squamous cell carcinoma:: role of the human papillomavirus in tumour progression
    De Petrini, M
    Rittà, M
    Schena, M
    Chiusa, L
    Campisi, P
    Giordano, C
    Landolfo, V
    Pecorari, G
    Landolfo, S
    NEW MICROBIOLOGICA, 2006, 29 (01) : 25 - 33
  • [9] Network-Based Predictors of Progression in Head and Neck Squamous Cell Carcinoma
    Sanati, Nasim
    Iancu, Ovidiu D.
    Wu, Guanming
    Jacobs, James E.
    McWeeney, Shannon K.
    FRONTIERS IN GENETICS, 2018, 9
  • [10] Immune-scoring in head and neck squamous cell carcinoma: a scoping review
    Zamani, Raha
    Rezaei, Nima
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (08) : 1009 - 1017